A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT02991911 · COMPLETED

Trial details

NCT number: NCT02991911
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer

Start date: 2017-01-06
Primary completion: 2019-09-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.